Literature DB >> 30145354

Too sweet: Problems of protein glycation in the eye.

Eloy Bejarano1, Allen Taylor2.   

Abstract

Laboratory and epidemiological data indicate that high blood sugar levels and/or consuming high glycemia diets are linked to multiple age-related diseases, including age-related macular degeneration, cataract, Parkinson's disease, Alzheimer's disease, diabetic retinopathy, and, apparently glaucoma. High concentrations of blood sugar and perturbations of the systems that regulate blood sugar lead to the accumulation of advanced-glycation end products (AGEs). AGEs are toxic compounds that are formed from the combination of sugars and their metabolites with biomolecules in a non-enzymatic biochemical reaction called glycation. In vitro and in vivo data indicate that high sugar consumption is associated with accumulation of AGEs in a variety of human tissues. Hyperglycemia, along with an oxidative environment and limited cell proliferation in many ocular tissues, encourages formation and precludes dilution of AGEs and associated damage by cell division. These circumstances make many eye tissues vulnerable to glycation-derived damage. Here, we summarize research regarding glycation-induced ocular tissue dysfunction and its contribution to the onset and development of eye disorders. We also discuss how management of carbohydrate nutrition may provide a low-cost way to ameliorate the progression of AGEs-related diseases, including age related macular degeneration and some cataracts, as they do for cardiovascular disease and diabetes.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Advanced glycation-end products; Age-related macular degeneration; Aging; Cataracts; Cornea; Diabetes; Diabetic retinopathy; Glycemic index; Optic nerve; Retina; Trabecular meshwork; Vitreous

Mesh:

Substances:

Year:  2018        PMID: 30145354      PMCID: PMC8351608          DOI: 10.1016/j.exer.2018.08.017

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  152 in total

1.  CD36, a member of class B scavenger receptor family, is a receptor for advanced glycation end products.

Authors:  N Ohgami; R Nagai; M Ikemoto; H Arai; A Kuniyasu; S Horiuchi; H Nakayama
Journal:  Ann N Y Acad Sci       Date:  2001-12       Impact factor: 5.691

2.  Evidence of a glycemic threshold for the development of cataracts in diabetic rats.

Authors:  S Swamy-Mruthinti; S M Shaw; H R Zhao; K Green; E C Abraham
Journal:  Curr Eye Res       Date:  1999-06       Impact factor: 2.424

3.  A quick, simple method for detecting circulating fluorescent advanced glycation end-products: Correlation with in vitro and in vivo non-enzymatic glycation.

Authors:  Marika Villa; Mariacristina Parravano; Arianna Micheli; Lucia Gaddini; Andrea Matteucci; Cinzia Mallozzi; Francesco Facchiano; Fiorella Malchiodi-Albedi; Flavia Pricci
Journal:  Metabolism       Date:  2017-03-09       Impact factor: 8.694

4.  Immunochemical evidence for increased formation of advanced glycation end products and inhibition by aminoguanidine in diabetic rat lenses.

Authors:  K Matsumoto; K Ikeda; S Horiuchi; H Zhao; E C Abraham
Journal:  Biochem Biophys Res Commun       Date:  1997-12-18       Impact factor: 3.575

5.  Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes.

Authors:  T A Gardiner; H R Anderson; A W Stitt
Journal:  J Pathol       Date:  2003-10       Impact factor: 7.996

Review 6.  Sweetening of the global diet, particularly beverages: patterns, trends, and policy responses.

Authors:  Barry M Popkin; Corinna Hawkes
Journal:  Lancet Diabetes Endocrinol       Date:  2015-12-02       Impact factor: 32.069

7.  Oral AGE restriction ameliorates insulin resistance in obese individuals with the metabolic syndrome: a randomised controlled trial.

Authors:  Helen Vlassara; Weijing Cai; Elizabeth Tripp; Renata Pyzik; Kalle Yee; Laurie Goldberg; Laurie Tansman; Xue Chen; Venkatesh Mani; Zahi A Fayad; Girish N Nadkarni; Gary E Striker; John C He; Jaime Uribarri
Journal:  Diabetologia       Date:  2016-07-29       Impact factor: 10.122

8.  Secondary intervention with aminoguanidine retards the progression of diabetic retinopathy in the rat model.

Authors:  H P Hammes; D Strödter; A Weiss; R G Bretzel; K Federlin; M Brownlee
Journal:  Diabetologia       Date:  1995-06       Impact factor: 10.122

9.  Accumulation of Maillard reaction products in skin collagen in diabetes and aging.

Authors:  D G Dyer; J A Dunn; S R Thorpe; K E Bailie; T J Lyons; D R McCance; J W Baynes
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

10.  Kinetics of glycoxidation of bovine serum albumin by glucose, fructose and ribose and its prevention by food components.

Authors:  Izabela Sadowska-Bartosz; Sabina Galiniak; Grzegorz Bartosz
Journal:  Molecules       Date:  2014-11-17       Impact factor: 4.411

View more
  17 in total

Review 1.  Corneal injury: Clinical and molecular aspects.

Authors:  Brayden Barrientez; Sarah E Nicholas; Amy Whelchel; Rabab Sharif; Jesper Hjortdal; Dimitrios Karamichos
Journal:  Exp Eye Res       Date:  2019-06-22       Impact factor: 3.467

2.  The effect of a-Lipoic acid (ALA) on oxidative stress, inflammation, and apoptosis in high glucose-induced human corneal epithelial cells.

Authors:  Zhen Li; Yu Han; Yan Ji; Kexin Sun; Yanyi Chen; Ke Hu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-09-05       Impact factor: 3.535

3.  Diet Quality Scores Are Positively Associated with Whole Blood-Derived Mitochondrial DNA Copy Number in the Framingham Heart Study.

Authors:  Jiantao Ma; Xue Liu; Yuankai Zhang; Hanning Cheng; Wencheng Gao; Chao-Qiang Lai; Stacey Gabriel; Namrata Gupta; Ramachandran S Vasan; Daniel Levy; Chunyu Liu
Journal:  J Nutr       Date:  2022-03-03       Impact factor: 4.798

4.  Effect of Berberine on Glycation, Aldose Reductase Activity, and Oxidative Stress in the Lenses of Streptozotocin-Induced Diabetic Rats In Vivo-A Preliminary Study.

Authors:  Maria Zych; Weronika Wojnar; Magdalena Kielanowska; Joanna Folwarczna; Ilona Kaczmarczyk-Sedlak
Journal:  Int J Mol Sci       Date:  2020-06-16       Impact factor: 5.923

5.  Evaluation of Relevance between Advanced Glycation End Products and Diabetic Retinopathy Stages Using Skin Autofluorescence.

Authors:  Yuji Takayanagi; Mikihiro Yamanaka; Jo Fujihara; Yotaro Matsuoka; Yuko Gohto; Akira Obana; Masaki Tanito
Journal:  Antioxidants (Basel)       Date:  2020-11-09

6.  Racemization in cataractous lens from diabetic and aging individuals: analysis of Asp 58 residue in αA-crystallin.

Authors:  Xiang-Jia Zhu; Ke-Ke Zhang; Wen-Wen He; Jiao Qi; Yi Lu
Journal:  Aging (Albany NY)       Date:  2021-06-07       Impact factor: 5.682

Review 7.  Protein posttranslational modification (PTM) by glycation: Role in lens aging and age-related cataractogenesis.

Authors:  Xingjun Fan; Vincent M Monnier
Journal:  Exp Eye Res       Date:  2021-07-20       Impact factor: 3.770

8.  High complexity of toxic reactions: parallels between products of oxidative stress and advanced glycation end products.

Authors:  Hermann M Bolt
Journal:  Arch Toxicol       Date:  2020-04-01       Impact factor: 5.153

9.  Autophagic receptor p62 protects against glycation-derived toxicity and enhances viability.

Authors:  Gemma Aragonès; Kalavathi Dasuri; Opeoluwa Olukorede; Sarah G Francisco; Carol Renneburg; Caroline Kumsta; Malene Hansen; Shun Kageyama; Masaaki Komatsu; Sheldon Rowan; Jonathan Volkin; Michael Workman; Wenxin Yang; Paula Daza; Diego Ruano; Helena Dominguez-Martín; José Antonio Rodríguez-Navarro; Xue-Liang Du; Michael A Brownlee; Eloy Bejarano; Allen Taylor
Journal:  Aging Cell       Date:  2020-11-04       Impact factor: 9.304

Review 10.  Dietary Patterns, Carbohydrates, and Age-Related Eye Diseases.

Authors:  Sarah G Francisco; Kelsey M Smith; Gemma Aragonès; Elizabeth A Whitcomb; Jasper Weinberg; Xuedi Wang; Eloy Bejarano; Allen Taylor; Sheldon Rowan
Journal:  Nutrients       Date:  2020-09-18       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.